Stark, Richardedd

Prof Richard Stark

Neurologist; Adjunct Clinical Professor, Department of Neuroscience, Monash University
Richard Stark graduated from Monash University (top student) and trained at the Alfred Hospital, Melbourne, The London Hospital and the National Hospitals for Nervous Diseases, Queen Square, in London. He is Adjunct Clinical Professor, Department of Neuroscience, Monash University and Neurologist at the Alfred Hospital. His major area of clinical interest has been headache: the headache clinic at the Alfred is now the largest in Australia and many young Australian headache specialists have trained there. He has published extensively on clinical aspects of migraine management. He is passionate about teaching, especially clinical skills. He has been Chair of the WCN Tournament Committee He is Past Treasurer and Trustee of the World Federation of Neurology and Past President of the Australia New Zealand Headache Society. He was awarded the E Graham Robertson Award for services to Neuroscience and to ANZAN in 2009, the ANZAN Medal for services to Neurology and to ANZAN in 2012 and was the 2022 Noshir Wadia Orator at the AOCN/IAN meeting. He was made a Member of the Order of Australia (AM) for service to neurology and professional organisations in June 2019.

More from this expert

In this Product Explainer, Neurologist A/Prof Richard Stark explains the role of eletriptan hydrobromide tablets in the acute treatment of migraine with or without aura in adults (6 mins).

Videos iconVideos

Migraine is more than just a headache - It is a useful diagnosis to make because there lots of treatment options

Podcasts iconPodcasts

In today's podcast, Prof Richard Stark covers causes, types and treatment approaches for acute migraine, including medication use, patients diaries and the latest advancement in management.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.